Factor XII deficiency in women with recurrent miscarriage

Gynecologic and Obstetric Investigation

Volumn 49, Issue 2, 2000, Pages 80-83

  Yamada, Hideto ^a   Kato, Emi H ^a   Ebina, Yasuhiko ^a   Kishida, Tatsuro ^a   Hoshi, Nobuhiko ^a   Kobashi, Gen ^a   Sakuragi, Noriaki ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Coagulation; Factor XII; Growth factor; Pregnancy; Recurrent abortions

Indexed keywords

BLOOD CLOTTING FACTOR 12;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR 12 DEFICIENCY; CLINICAL ARTICLE; FEMALE; FETUS DEVELOPMENT; HUMAN; JAPAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RECURRENT ABORTION; SCREENING; THROMBOPHILIA;

EID: 0033957115     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000010220     Document Type: Article

References (35)

1. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hilsman MV, Girolami A, ten Cate JW, Prins MH: The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996;75:387-388.
2. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, Fontcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, van der Meer FJ: Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-916.
3. Haan L, Lundberg PA: Congenital hypofibrinogenemia and recurrent abortion. Br J Obstet Gynaecol 1987;85:790-793.
4. Duckert F. The fibrin stabilizing factor, factor XIII. Blut 1973;26:177-179.
5. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF: Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993;122:606-615.
6. Mannhalter C, Fischer M, Hopmeier P, Deutsch E: Factor XII activity and antigen concentration in patients suffering from recurrent thrombosis. Fibrinolysis 1987;1:259-263.
7. McPherson RA: Thromboembolism in Hageman trait. Am J Clin Pathol 1977;68:420-423.
8. Dyerberg J, Stoffersen E: Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol 1980;63:278-282.
9. Lammle B, Wuillemin WA, Huber I, Krauskopf M, Zurcher C, Pflugshaupt R, Furlan M: Thromboembolism and bleeding tendency in congenital factor XII deficiency: A study on 74 subjects from 14 Swiss families. Thromb Haemost 1991;65:117-121.
10. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M: The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/ or arterial thromboembolism. Thromb Haemost 1992;68:285-290.
11. Winter M, Gallimore M, Jones DW: Should factor XII assays be included in thrombophilia screening? Lancet 1995;346:52.
12. Mangal AK, Naiman SC: Hageman factor deficiency and oral contraceptives. Lancet 1980;i: 774.
13. Goodnough LT, Saito H, Ratnoff OD: Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 1983;62:248-255.
14. Lodi S, Isa L, Pollini E, Bravo AF, Scalvini A: Defective intrinsic fibrinolytic activity in a patient with severe factor XII-deficiency and myocardial infarction. Scand J Haematol 1984; 33:80-82.
15. Penny WJ, Colvin BT, Brooks N: Myocardial infarction with normal coronary arteries and factor XII deficiency. Br Heart J 1985;53:230-234.
16. Hellstern P, Kohler M, Schmengler K, Doenecke P, Wenzel E: Arterial and venous thrombosis and normal response to streptokinase treatment in a young patient with severe Hageman factor deficiency. Acta Haematol 1983;69: 123-126.
17. Kluft C, Dooijewaard G, Emeis JJ: Role of the contact system in fibrinolysis. Semin Thromb Hemost 1987;13:50-68.
18. Schved JF, Gris JC, Neveu S, Dupaigne D, Mares P: Factor XII congenital deficiency and early spontaneous abortion. Fertil Steril 1989; 52:335-336.
19. Braulke I, Pruggmayer M, Melloh P, Hinney B, Kostering H, Gunther E: Factor XII (Hageman) deficiency in women with habitual abortion: New subpopulation of recurrent aborters? Fertil Steril 1993;59:98-101.
20. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hedon B, Mares P: Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost 1997; 77:1096-1103.
21. Balasch J, Reverter JC, Fabregues F, Tassies D, Rafel M, Creus M, Vanrell JA: First-trimester repeated abortion is not associated with activated protein C resistance. Hum Reprod 1997; 12:1094-1097.
22. Dizon-Townson DS, Kinney S, Branch DW, Ward K: The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997;34:217-223.
23. Pauer HU, Neesen J, Hinney B: Factor V Leiden and its relevance in patients with recurrent abortions. Am J Obstet Gynecol 1998;178: 629.
24. Saito H: Contact factors in health and disease. Semin Thromb Hemost 1987;13:36-49.
25. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, Gleicher N: Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995;345:1340-1342.
26. Kwak JYH, Kwak FM, Ainbinder SW, Ruiz AM, Beer AE: Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996;35:363-369.
27. Ruiz JE, Kwak JYH, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AR: Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortions. Am J Reprod Immunol 1996;35:370-375.
28. Yahata T, Kurabayashi T, Honda A, Takakuwa K, Tanaka K, Abo T: Decrease in the proportion of granulated CD56+ T-cells in patients with a history of recurrent abortion. J Reprod Immunol 1998;38:63-73.
29. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995;373: 702-705.
30. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699-702.
31. Cool DE, MacGilivray RT: Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5′-flanking region. J Biol Chem 1987;262: 13662-13673.
32. Miyazawa K, Wang Y, Minoshima S, Shimizu N, Kitamura N: Structural organization and chromosomal localization of the human hepatocyte growth factor activator gene: Phylogenetic and functional relationship with blood coagulation factor XII, urokinase, and tissue-type plasminogen activator. Eur J Biochem 1998;258:355-361.
33. Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y, Kitamura N: Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 1995;229:257-261.
34. Kanaji T, Okamura T, Niho Y, Sugiyama M: Molecular analysis of a family with factor XII deficiency. Identification of 126 Arg to Pro substitution (abstract). Blood 1995;86:876.
35. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y: A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998;91:2010-2014.